- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01538186
Treatment Of Coronary Bifurcation Lesions: Stentcovering Of The Side Branch With And Without PCI Of The Side Branch: A Retrospective Analysis Of All Consecutive Patients
This retrospective observational study included patients (pts) with percutaneous coronary intervention (PCI) of a de novo coronary bifurcation lesion in one German center between January 2008 - August 2011. The investigators included all consecutive patients where the side branch was covered with a stent. Patients with ACS/cardiogenic shock were not excluded.
Two different methods were compared: group A represents patients with a simple strategy without any treatment of the side branch (SB). Group B consisted of patients where the SB was treated (PCI and/or stenting).
For the treatment of bifurcation lesions we used the concept of "provisional stenting", indications for the treatment of the SB were residual stenosis > 50 %, TIMI flow reduction < 2. Final-kissing PCI was intended in all patients of group B.
MACE during follow-up was evaluated in all patients.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Rheinland-Pfalz
-
Neustadt/Weinstrasse, Rheinland-Pfalz, Germany, 67434
- Hetzelstift
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All consecutive patients with a bifurcation lesion, where the side branch was covered with a stent placed inside the main branch.
Exclusion Criteria:
- Patients with an in-stent-restenosis, patients with a therapy using a drug coated balloon during the procedure (inside the main branch and/or the side branch) and patients where the side branch was not covered by the stent inside the main branch.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
PCI without treating the side branch
|
|
PCI with treating the side branch
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Major adverse cardiac outcome
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Hetzel01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Bifurcation Lesions
-
Nova-Med Medical Research AssociationCompletedCoronary Bifurcation Lesions
-
Acotec Scientific Co., LtdShanghai Zhongshan HospitalRecruitingCoronary Bifurcation LesionsChina
-
Nanjing First Hospital, Nanjing Medical UniversityCompletedCoronary Bifurcation LesionsChina
-
Yonsei UniversityWithdrawnCoronary Bifurcation Lesions
-
Universitaire Ziekenhuizen KU LeuvenBiosensors InternationalUnknownTrue Coronary Bifurcation LesionsBelgium
-
University of East AngliaNorfolk and Norwich University Hospitals NHS Foundation TrustRecruitingCoronary Bifurcation LesionsUnited Kingdom
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Recruiting
-
Minneapolis Heart Institute FoundationRecruitingCoronary Artery Disease | Coronary Bifurcation LesionsUnited States
-
Dongguan TT MedicalPeking University First HospitalRecruitingCoronary Bifurcation LesionChina